TY - JOUR
T1 - Implementing lifestyle medicine with medication therapy management services to improve patient-centered health care
AU - Lenz, Thomas L.
AU - Monaghan, Michael S.
PY - 2011/1/1
Y1 - 2011/1/1
N2 - Objective: To describe a patient-centered medication therapy management (MTM) program that focuses on lifestyle medicine. Setting: Community pharmacy in Omaha, NE, from August 2008 to September 2010. Practice description: Traditional MTM services are combined with lifestyle medicine interventions for employees of a self-insured organization who have dyslipidemia, hypertension, and/or diabetes. Program participants meet one-on-one with a pharmacist 12 times during the first year of the program to ensure proper drug therapy and modify lifestyle behaviors (physical activity, nutrition, weight control, sleep, stress, and alcohol and tobacco use) through individualized programming. Practice innovation: Several patient-centered activities have been developed for the program with an emphasis on modifying lifestyle behaviors in conjunction with medications to manage participants' chronic condition. In addition, a new specialty position in health care is being developed (the ambulatist) that focuses on maintaining the ambulatory status of individuals with chronic medical conditions through appropriate drug therapy, lifestyle medicine, and care coordination. Main outcome measures: Biometric data collection and participant survey data at baseline and after 12 months. Results: Pilot data for 15 participants showed improvements in all measurements, including blood cholesterol, low-density lipoprotein cholesterol, blood glucose, body weight, physical activity level, fruit and vegetable intake, risk for myocardial infarction, risk for any cardiovascular disease event, self-reported unhealthy days, and qualitative survey data. Conclusion: Pharmacists are in an ideal position to implement lifestyle medicine strategies in combination with MTM services to enhance patient-centered health care in a community pharmacy setting.
AB - Objective: To describe a patient-centered medication therapy management (MTM) program that focuses on lifestyle medicine. Setting: Community pharmacy in Omaha, NE, from August 2008 to September 2010. Practice description: Traditional MTM services are combined with lifestyle medicine interventions for employees of a self-insured organization who have dyslipidemia, hypertension, and/or diabetes. Program participants meet one-on-one with a pharmacist 12 times during the first year of the program to ensure proper drug therapy and modify lifestyle behaviors (physical activity, nutrition, weight control, sleep, stress, and alcohol and tobacco use) through individualized programming. Practice innovation: Several patient-centered activities have been developed for the program with an emphasis on modifying lifestyle behaviors in conjunction with medications to manage participants' chronic condition. In addition, a new specialty position in health care is being developed (the ambulatist) that focuses on maintaining the ambulatory status of individuals with chronic medical conditions through appropriate drug therapy, lifestyle medicine, and care coordination. Main outcome measures: Biometric data collection and participant survey data at baseline and after 12 months. Results: Pilot data for 15 participants showed improvements in all measurements, including blood cholesterol, low-density lipoprotein cholesterol, blood glucose, body weight, physical activity level, fruit and vegetable intake, risk for myocardial infarction, risk for any cardiovascular disease event, self-reported unhealthy days, and qualitative survey data. Conclusion: Pharmacists are in an ideal position to implement lifestyle medicine strategies in combination with MTM services to enhance patient-centered health care in a community pharmacy setting.
UR - http://www.scopus.com/inward/record.url?scp=79959530802&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79959530802&partnerID=8YFLogxK
U2 - 10.1331/JAPhA.2011.10169
DO - 10.1331/JAPhA.2011.10169
M3 - Article
C2 - 21382808
AN - SCOPUS:79959530802
VL - 51
SP - 184
EP - 188
JO - Journal of the American Pharmaceutical Association. American Pharmaceutical Association
JF - Journal of the American Pharmaceutical Association. American Pharmaceutical Association
SN - 1544-3191
IS - 2
ER -